Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,014 | 179,126 | 1,051 | 529 | 10,739 |
| Gross Profit | 1,014 | 179,126 | 1,051 | 529 | 10,739 |
| Operating Expenses | 6,978 | 10,218 | 6,341 | 9,188 | 9,251 |
| Operating Income | -5,964 | 168,908 | -5,290 | -8,659 | 1,488 |
| Interest Expense | 18 | 17 | 18 | 23 | 28 |
| Other Income | 839 | 804 | 1,552 | 940 | 1,063 |
| Pre-tax Income | -5,143 | 169,695 | -3,756 | -7,742 | 2,523 |
| Net Income Continuous | -5,143 | 169,695 | -3,756 | -7,742 | 2,523 |
| Net Income | $-5,143 | $169,695 | $-3,756 | $-7,742 | $2,523 |
| EPS Basic Total Ops | -0.03 | 0.88 | -0.01 | -0.04 | 0.01 |
| EPS Basic Continuous Ops | -0.03 | 0.88 | -0.02 | -0.04 | 0.01 |
| EPS Diluted Total Ops | -0.03 | 0.87 | -0.01 | -0.04 | 0.01 |
| EPS Diluted Continuous Ops | -0.03 | 0.87 | -0.02 | -0.04 | 0.01 |
| EPS Diluted Before Non-Recurring Items | -0.03 | 0.87 | -0.01 | -0.04 | 0.01 |
| EBITDA(a) | $-5,953 | $168,919 | $-5,279 | $-8,648 | $1,499 |